Could tattoos be a risk factor for malignant lymphoma? Find out about this and more in today's PeerDirect Medical News Podcast.

This week's stories include an endoscopic ablation technique targeting ghrelin production showing results for significant weight loss, research that prior immunity to SARS-CoV-2 does not inhibit response to updated COVID-19 vaccines, and a study from the 2024 Heart Rhythm Society Meeting suggesting oral anticoagulant discontinuation after atrial fibrillation catheter ablation may be feasible and safe.

Drs. David Eichenbaum and Priya Vakharia share their insights on biosimilars in the treatment of retinal disease in the United States.

Is there potential for recovery in patients who are withdrawn from life support? Find out about this and more in today's PeerDirect Medical News Podcast.

Drs. David Eichenbaum and Priya Vakharia share their insights on biosimilars in the treatment of retinal disease in the United States.

Drs. Alicia Morgans and Jonathan Rosenberg share their insights into some interesting abstracts from the 2024 ASCO GU symposium: one covering a model to help predict response to neoadjuvant chemotherapy in patients with muscle invasive UC, and another regarding results from the PemCab study of pembrolizumab and cabozantinib in first‑line advanced UC.

Drs. Jonathan Rosenberg and Alicia Morgans share their insights into some late-breaker abstracts presented at the 2024 ASCO GU symposium in San Francisco. The first is a subgroup analysis from EV‑302 with enfortumab vedotin and pembrolizumab, and the other is AMBASSADOR, which looks at adjuvant pembrolizumab in locally advanced and muscle invasive urothelial cancer.

Drs. Alicia Morgans and Jonathan Rosenberg share their insights into therapeutic sequencing in patients with advanced urothelial cancer, reviewing patient selection and timing, options following progression on immunotherapy, and future therapeutic agents such as HER2‑targeted ADCs.

Can antibodies be used as biomarkers of naturally resolving peanut allergy? Find out about this and more in today's PeerDirect Medical News Podcast.

Drs. Rosenberg and Morgans share their insights into neoadjuvant therapy in the management of patients with muscle invasive urothelial carcinoma, including patient‑ and treatment‑related factors that may influence decision making, bladder‑preservation, and the future of neoadjuvant therapy with immunotherapy and ADCs.